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Evaluating the systolic function of the left ventricle (LV) is important in the hemodynamic management of the critically ill patients
with circulatory failure. Echocardiography is considered the standard monitor for estimating the LV function at the bedside in
the intensive care unit. However, it requires a trained operator and is not a real-time monitoring tool. For monitoring of the
systolic function, the pulmonary artery catheter has been the gold standard for a long time. However, now there are alternatives
to this device, with transpulmonary thermodilution being one of them. This paper provides an overview of the usefulness of the
transpulmonary thermodilution-derived indices for assessing systolic function at the bedside.
1.Introduction
Cardiovascular monitoring is essential for diagnostic and
therapeutic management of critically ill patients and assess-
ing the systolic function of the left ventricle (LV) is a key
component in this strategy.
Echocardiography has become the standard tool for
measuring LV ejection fraction (LEVF) at the bedside in
the intensive care unit (ICU). This type of monitoring gives
the physician a rapid and accurate etiologic diagnosis of the
cause of hemodynamic instability in the critically ill patient.
Thus, a hemodynamically unstable patient is a good reason
to perform a cardiac ultrasound [1]. However, the use of
echocardiography requires an expensive device and a trained
operator. Additionally, conventional echocardiography can-
not be considered as continuous monitoring, and although
there is a commercially available continuous model, it has
not received widespread acceptance.
The pulmonary artery catheter (PAC) has been the gold
standard for monitoring of systolic function for decades, but
concerns have been raised about its safety and the clinical
usefulness of the data it provides [2–4]; thus, alternative
monitoring methods have been evaluated.
More recently, the transpulmonary thermodilution tech-
nique with single thermal indicator (incorporated into
the PiCCO monitor, Pulsion Medical System, Munich,
Germany) was proposed as a “less invasive” hemodynamic
monitoring system for critically care patients. The sys-
tem provides intermittent (transpulmonary thermodilution-
derived) and continuous (pulse contour-derived) assessment
of cardiac output and estimations of intrathoracic volumes
(intrathoracic blood volume, global-end diastolic volume,
and extravascular lung water). Accuracy of cardiac output
calculation using the PiCCO system has been demonstrated
in several clinical studies [5–9] and intrathoracic blood
volume (blood volume contained in the heart and in the
intrathoracic vessels) and global end-diastolic volume (the
volume of blood contained in the four cardiac chambers
at the end of the diastole) have been shown to provide
reliable and more sensitive estimates of cardiac preload than
cardiacﬁllingpressuresobtainedwiththecentralvenousand
pulmonary artery catheters [10–17]. On the other hand, the
use of the transpulmonary thermodilution arterial catheters
do not increase the risk of complications when compared
with the commonly used short peripheral arterial catheters
or pulmonary artery catheters [18].2 Anesthesiology Research and Practice
The PiCCO system also provides two transpulmonary
thermodilution-derived indices of cardiac systolic function:
the cardiac function index (CFI) and the global ejection
fraction (GEF) which are automatically calculated by the
monitor.
1.1. Calculation of CFI and GEF by Transpulmonary Ther-
modilution. A thermistor placed into a femoral, brachial,
or axillary arterial catheter measures the downstream tem-
perature changes induced by the injection of a cold saline
bolus into the superior vena cava. The monitor calculates
cardiac output (CO) from the thermodilution curve, using
the Stewart-Hamilton algorithm, and also the mean transit
time (MTt) and the exponential down slope time (DSt). The
result of the product of CO times MTt is the intrathoracic
thermal volume (ITTV):
ITTV = CO ×MTt. (1)
And the product of CO times DSt is the pulmonary
thermal volume (PTV):
PTV = CO × DSt. (2)
The diﬀerence between ITTV and PTV is the global end-
diastolic volume (GEDV) which represents the volume of
blood contained in the four chambers:
GEDV = ITTV −PTV = CO × (MTt − DSt)( mL). (3)
The CFI is deﬁned as the ratio of cardiac output to the global
end-diastolic volume:
CFI =
CO
GEDV

min
−1

. (4)
The GEF is deﬁned as the ratio of the stroke volume (SV) to
the quarter of the global end-diastolic volume:
GEF =
SV
(GEDV/4)
(%). (5)
CFI and GEF are, therefore, global ejection phase indices
since they are the ratio of CO or stroke volume to the global
end-diastolic volume of the heart. Therefore the diﬀerence
between the two indices is that GEF takes into account the
heart rate and stoke volume, and the GEF only considers the
stroke volume. These indices are obtained very easily by the
physician at the bedside while only an experienced operator
can get similar information using echocardiography [17].
The purpose of this paper is to review the diﬀerent
studies that assess the accuracy of these transpulmonary
thermodilution-derivedindicesfortheestimationofleftven-
tricular systolic function in the ICU patients at the bedside.
2. Evaluationof the Transpulmonary
Thermodilution-DerivedIndices with
theEchocardiography
In 2004, Combes et al. used transesophageal echocardiogra-
phy to compare these indices with left ventricular fractional
area of change (LVFAC) [17]. They studied 33 adult ICU
patients with no isolated right ventricular dysfunction in a
prospective, open clinical study. During the measurements,
echocardiography identiﬁed 3 patients with isolated right
ventricularfailure,in whichtranspulmonary thermodilution
underestimated LVFAC. In the results, signiﬁcant correla-
tions were established between LVFAC and CFI (r = 0.87,
n = 30, P<0.0001) or GEF (r = 0.82, n = 30, P<0.0001).
The mean diﬀerences between LVFAC and LVFAC estimated
with CFI or GEF were 0.8 ± 8.5% (range −17 to 14%) and
0.8 ± 9.0% (range −21 to 19%), respectively. Area under the
receiver operating characteristics curves for the estimation of
LVFAC ≥ 40% using CFI or GEF was 0.92. Values of CFI >
4a n dG E F> 18% estimated LVFAC ≥ 40% with respective
sensitivities of 86 and 88% and speciﬁcities of 88 and 79%.
Additionally, signiﬁcant correlations were found between
changes of LVFAC and CFI and GEF over time. The authors
concluded that in mechanically ventilated ICU patients, GEF
and CFI provide reliable estimations of LV systolic function,
butmayunderestimateitincasesofisolatedrightventricular
failure.
Five years later, Jabot et al. conducted a prospective study
in 48 medical ICU patients with acute circulatory failure, to
assess whether CFI could actually behave as an indicator of
left ventricular systolic function [19]. For this purpose they
tested if CFI fulﬁlled the following criteria: (1) it increased
with inotropic stimulation (dobutamine infusion, n = 24);
(2) it was not altered by ﬂuid loading (500mL of saline, n =
24); (3) it correlated with the echocardiographic left ventric-
ular ejection fraction (LVEF). The authors simultaneously
measured LVEF (monoplane or biplane Simpson method)
and CFI at baseline, and after saline and dobutamine
administration. Volume expansion altered neither LVEF (47
± 11% to 47 ± 11%) nor CFI (4.5 ± 2.2 to 4.5 ± 2.1min−1),
dobutamine infusion signiﬁcantly increased LVEF (percent-
age of change: 32 ± 28%) and CFI (percentage of change: 29
± 22%). Considering the eﬀects of dobutamine, there was a
signiﬁcant correlation between the changes in CFI and the
changes in LVEF (r = 0.65, P = 0.0001). Finally, a CFI <
3.2min−1 predicted an LVEF of ≤35% with a sensitivity of
81% and speciﬁcity of 88%. The authors concluded that CFI
fulﬁlled the criteria required from a clinical indicator of left
ventricular global systolic function and accurately tracked
the eﬀects of inotropic therapy.
Finally, our group conducted a prospective clinical study
with 35 ICU patients, excluding those with severe changes
in contractility and in nonsinus rhythm [20]. We compared
these indices with the left ventricular ejection fraction
obtained by transthoracic echocardiography. In the results
we found signiﬁcant correlations between the left ventricular
ejection fraction and the GEF (r = 0.79, P<0.001) and the
CFI (r = 0.66, P<0.001). The mean diﬀerences between
LVEF and LVEF estimated with GEF or CFI (Figure 1)w e r e
1.05 ± 10.2% (range −19 to 29.1%) and 0.001 ± 12.4%
(range −24.3 to 24.3%), respectively. For predicting an LVEF
of less than 40%, the area under the curve was 0.879 for
the GEF and 0.805 for the CFI. Furthermore, a GEF of less
than 13.5% and a CFI of less than 3.15min−1 predicted an
LVEF of less than 40% with sensitivities of 97% and 96% and
speciﬁcitiesof85%and77%,respectively.Weconcludedthat
in patients without marked changes in contractility, the GEFAnesthesiology Research and Practice 3
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Figure 1: Bland-Altman analyses of agreement between GEF (a)
or CFI (b) and the LVEF measured by the Simpson method. The
central line is the mean diﬀerence (bias) between the two methods
whereas the outer lines represent the two SD limits of agreement.
From Belda et al. [18] with permission.
and the CFI oﬀer a reliable and simple way to assess the left
ventricular ejection fraction.
3.Identifying CardiacDysfunctioninAcute
HeartFailureandSepticPatients
In 2009, Ritter et al. designed an observational study com-
paring the cardiac function of patients with acute heart
failure (AHF) or sepsis using the pulmonary artery catheter
and the PiCCO technology [21]. Twelve patients with AHF
and nine patients with severe sepsis or septic shock had
four simultaneous hemodynamic measurements by PAC or
PiCCO during a 24-hour time period. In the results, com-
pared to septic patients, AHF patients had signiﬁcantly lower
cardiac index (CI), CFI, GEF, mixed venous oxygen satura-
tion (SmvO2), and pulmonary vascular permeability index
(PVPI), but higher pulmonary artery occlusion pressure
(PAOP). The mean values in the groups for sepsis and AHF
were, respectively: CI (PiCCO) 4.2 versus 2.9L·min−1·m−2,
CI (PAC) 4.3 versus 2.7L·min−1·m−2,C F I6 . 2v e r s u s
2.7min−1, GEF 23 versus 13%, SmvO2 69 versus 54%, PVPI
2.8 versus 2.6 and PAOP 17 versus 20mmHg. There were
no signiﬁcant diﬀerences between the two groups in the
extra lung water index (ELWI, mean values): 16.7 versus
15.5mL·kg−1. Additionally, PAOP did not correlate with
ELWI and PVPI either in septic shock or in AHF patients.
All patients with a CFI less than 4.5min−1 had a SmvO2
not greater than 70%. In both groups, the CFI show a weak
but statistically signiﬁcant correlation with the left ventricu-
lar stroke work index (sepsis: r2 = 0.30, P<0.05; AHF: r2 =
0.23, P<0.05) and the cardiac power (sepsis: r2 = 0.39, P<
0.05; AHF: r2 = 0.45, P<0.05). The authors concluded that
in critically ill medical patients, assessment of cardiac func-
tion using the transpulmonary thermodilution technique is
an alternative to the PAC. Furthermore, a low CFI identiﬁes
cardiac dysfunction in both AHF and septic patients.
4. Conclusions
The transpulmonary thermodilution-derived indices, car-
diacfunctionindex(CFI)andglobalejectionfraction(GEF),
can be considered as useful indicators of left ventricular
globalsystolicfunction.Infact,bothcouldhelpthephysician
identify, easily and at the bedside, alterations in the left ven-
tricular ejection fraction. On the other hand, normal values
of these indices indicate a good systolic function and could
avoid the need for immediate echocardiographic evaluation.
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